JP2008524329A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008524329A5 JP2008524329A5 JP2007548319A JP2007548319A JP2008524329A5 JP 2008524329 A5 JP2008524329 A5 JP 2008524329A5 JP 2007548319 A JP2007548319 A JP 2007548319A JP 2007548319 A JP2007548319 A JP 2007548319A JP 2008524329 A5 JP2008524329 A5 JP 2008524329A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- pharmaceutical composition
- mammal
- pharmaceutically acceptable
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 208000010507 Adenocarcinoma of Lung Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 208000031671 Large B-Cell Diffuse Lymphoma Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 206010041067 Small cell lung cancer Diseases 0.000 claims 1
- 208000005017 glioblastoma Diseases 0.000 claims 1
- 201000005249 lung adenocarcinoma Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 201000006845 reticulosarcoma Diseases 0.000 claims 1
- 208000029922 reticulum cell sarcoma Diseases 0.000 claims 1
- 208000000587 small cell lung carcinoma Diseases 0.000 claims 1
- 230000020347 spindle assembly Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63772204P | 2004-12-21 | 2004-12-21 | |
| PCT/US2005/045563 WO2006068933A2 (en) | 2004-12-21 | 2005-12-15 | Mitotic kinesin inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008524329A JP2008524329A (ja) | 2008-07-10 |
| JP2008524329A5 true JP2008524329A5 (https=) | 2008-12-11 |
Family
ID=36602225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007548319A Withdrawn JP2008524329A (ja) | 2004-12-21 | 2005-12-15 | 有糸分裂キネシン阻害剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20080045492A1 (https=) |
| EP (1) | EP1831176A2 (https=) |
| JP (1) | JP2008524329A (https=) |
| CN (1) | CN101084194A (https=) |
| AU (1) | AU2005319455A1 (https=) |
| CA (1) | CA2589827A1 (https=) |
| WO (1) | WO2006068933A2 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007011647A2 (en) * | 2005-07-15 | 2007-01-25 | Kalypsys, Inc. | Inhibitors of mitotic kinesin ksp |
| US20100099712A1 (en) * | 2007-01-17 | 2010-04-22 | Laboratorios Del Dr. Esteve, S.A. | Substituted pyrazoline compounds with acat inhibition activity |
| EP1950202A1 (en) * | 2007-01-24 | 2008-07-30 | Laboratorios del Dr. Esteve S.A. | Substituted pyrazoline compounds, their preparation and use as medicaments with ACAT inhibition activity |
| AR068888A1 (es) | 2007-10-19 | 2009-12-16 | Schering Corp | Derivados de 1, 3, 4 - tiadiazol, una composicion farmaceutica que los comprende y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por la inhibicion de la quinesina ksp. |
| BRPI0817897A2 (pt) * | 2007-11-02 | 2019-09-24 | Methylgene Inc | composto, composição, e, métodos de inibição da atividade hdac, e de tratamento de uma doença responsiva a um inibidor de atividade hdac |
| JP5581219B2 (ja) | 2008-01-25 | 2014-08-27 | ミレニアム ファーマシューティカルズ， インコーポレイテッド | チオフェンおよびホスファチジルイノシトール３−キナーゼ（ｐｉ３ｋ）阻害薬としてのその使用 |
| US9090601B2 (en) | 2009-01-30 | 2015-07-28 | Millennium Pharmaceuticals, Inc. | Thiazole derivatives |
| US8796314B2 (en) | 2009-01-30 | 2014-08-05 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| WO2010090716A1 (en) | 2009-01-30 | 2010-08-12 | Millennium Pharmaceuticals, Inc. | Heteroaryls and their use as pi3k inhibitors |
| US8859768B2 (en) | 2010-08-11 | 2014-10-14 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| WO2012021611A1 (en) | 2010-08-11 | 2012-02-16 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| MX2013001660A (es) | 2010-08-11 | 2013-06-03 | Millenium Pharmaceuticals Inc | Heteroarilos y usos de los mismos. |
| TW201307309A (zh) | 2010-10-13 | 2013-02-16 | Millennium Pharm Inc | 雜芳基化合物及其用途 |
| BR112014006940A2 (pt) * | 2011-09-23 | 2017-04-04 | Bayer Ip Gmbh | uso de derivados de ácido 1-fenilpirazol-3-carboxílico 4-substituído como agentes contra estresse abiótico em plantas |
| WO2013096630A1 (en) * | 2011-12-23 | 2013-06-27 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| AR094929A1 (es) | 2013-02-28 | 2015-09-09 | Bristol Myers Squibb Co | Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2 |
| WO2014134391A1 (en) | 2013-02-28 | 2014-09-04 | Bristol-Myers Squibb Company | Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors |
| CN103992274A (zh) * | 2014-04-18 | 2014-08-20 | 南京安美科技有限公司 | 合成选择性非甾体抗炎镇痛药Celebrex(塞来昔布)的方法 |
| WO2026070814A1 (ja) * | 2024-09-30 | 2026-04-02 | 大日本印刷株式会社 | 重合性液晶化合物及びその製造方法、重合性組成物、重合体、位相差フィルム及びその製造方法、転写用積層体、光学部材及びその製造方法、並びに表示装置 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005533119A (ja) * | 2002-07-17 | 2005-11-04 | サイトキネティクス・インコーポレーテッド | 化合物、組成物、及び方法 |
| EP1773326A4 (en) * | 2004-07-01 | 2009-07-22 | Merck & Co Inc | INHIBITORS OF MITOTIC KINESINE |
| EP1868601A4 (en) * | 2005-04-07 | 2008-12-10 | Merck & Co Inc | MITOTIC KINESINE HEMMER |
-
2005
- 2005-12-15 US US11/793,090 patent/US20080045492A1/en not_active Abandoned
- 2005-12-15 CA CA002589827A patent/CA2589827A1/en not_active Abandoned
- 2005-12-15 WO PCT/US2005/045563 patent/WO2006068933A2/en not_active Ceased
- 2005-12-15 JP JP2007548319A patent/JP2008524329A/ja not_active Withdrawn
- 2005-12-15 CN CNA200580043954XA patent/CN101084194A/zh active Pending
- 2005-12-15 EP EP05854311A patent/EP1831176A2/en not_active Withdrawn
- 2005-12-15 AU AU2005319455A patent/AU2005319455A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008524329A5 (https=) | ||
| ME00937B (me) | Kombinovane terapije koje sadrže hinoksalinske inhibitore pi3k-alfa za upotrebu u liječenju kancera | |
| NO2017019I2 (no) | Enzalutamid eller et farmasøytisk akseptabelt salt derav | |
| NO20033651L (no) | Cancerbehandling | |
| CL2011001863A1 (es) | Compuestos derivados de fenilaminopirimidinas, inhibidores de quinasa del linfoma anaplastico; composicion farmaceutica; combinacion farmacologica; y su uso en el tratamiento de trastornos proliferativos tales como linfoma, osteosarcoma, melanoma o tumor de mama, renal y de prostata, entre otros (divisional solicitud 3552-07). | |
| MX2010002179A (es) | Composicion para el tratamiento de enfermedades neoplasicas. | |
| ECSP099436A (es) | Acilaminopirazoles como inhibidores de fgfr | |
| JP2011515481A5 (https=) | ||
| IL179714A (en) | Pharmaceutical preparation containing a history of 2-biphenyl-4-ram-3,2-dehydro-1h-quinazoline-4-on and its use in the preparation of cancer drugs and blood vessel formation | |
| WO2008103470A3 (en) | Oncogenic-ras-signal dependent lethal compounds | |
| JP2004504382A5 (https=) | ||
| IL191832A (en) | Pyridiazinone compounds and their use in the preparation of drugs for the treatment of tumors | |
| IN2012DN01964A (https=) | ||
| JP2007510667A5 (https=) | ||
| JP2010523696A5 (https=) | ||
| WO2009046842A3 (de) | Thialzolderivate zur behandlung von krebs | |
| FR2869540B1 (fr) | Compositions pharmaceutiques contenant des derives de b-carboline, et leur utilisation pour le traitement des cancers | |
| DE602006010834D1 (de) | Neue thiophensulfoximine zur behandlung von komplementvermittelten krankheiten und leiden | |
| MX2007003104A (es) | Nuevos derivados de ftalazinona, como inhibidores de cinasa aurora-a. | |
| WO2006061258A3 (en) | Cytotoxic agents comprising new taxanes | |
| GEP20125603B (en) | Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents | |
| EP2722060A3 (en) | Guanylyl cyclase C ligands | |
| YU11402A (sh) | Nova primena docetaksela za lečenje hepatoma | |
| WO2009061770A3 (en) | Method of inhibiting abcg2 and related treatments | |
| JP2009516719A5 (https=) |